Probiotic VSL#3 may tweak bile acids in IBD patients
NCT ID NCT01765439
First seen May 04, 2026 · Last updated Jun 19, 2026 · Updated 9 times
Summary
This study looks at whether the probiotic VSL#3 can change how bile acids work in people with Crohn's disease or ulcerative colitis. About 79 participants will take two sachets of VSL#3 daily for six weeks. Researchers will measure bile acid levels in blood and stool to see if the probiotic helps manage the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Iscare I.V.F.
Prague, 17004, Czechia
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VSL#3 probiotic (a mix of live bacteria)
What this could lead to
If it works, this could point toward a way to improve bile acid balance and reduce symptoms in people with inflammatory bowel disease.
What could go wrong
This is a small, early-stage study with no phase, so results may not lead to a proven treatment. The probiotic may not change bile acid levels as hoped.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.